The proposed cuts to medical research funding and removal of key experts within the Department of Health and Human Services have put the future of the U.S. public health infrastructure and biomedical research at extreme risk. We must urge Congress to continue their support of steady and robust federal agency leadership, federal biomedical research funding, and public health agency resources.

Let your lawmakers know that strong federal agency leadership and support of biomedical research are key pieces of the medical landscape in the United States.